0
     

Report Added
Report already added
Global Intravitreal Injectable Market Growth 2021-2026

Global Intravitreal Injectable Market Growth 2021-2026

According to this latest study, the 2021 growth of Intravitreal Injectable will have significant change from previous year. By the most conservative estimates of global Intravitreal Injectable market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ 13420 million in 2020. Over the next five years the Intravitreal Injectable market will register a 7.4% CAGR in terms of revenue, the global market size will reach US$ 17860 million by 2026.

This report presents a comprehensive overview, market shares, and growth opportunities of Intravitreal Injectable market by product type, application, key manufacturers and key regions and countries.

Segmentation by drug: breakdown data from 2016 to 2021, in Section 2.3; and forecast to 2026 in section 11.7.
Anti-VEGF
Steroids
Others

Segmentation by application: breakdown data from 2016 to 2021, in Section 2.4; and forecast to 2026 in section 11.8.
Macular Degeneration
Macular Edema
Uveitis
Retinal Vein Occlusion
Others

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in Chapter 3.
Regeneron Pharmaceuticals (Eylea)
Allergan
EyePoint Pharmaceuticals
Genentech
Kanghong Pharmaceutical
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered

2 Executive Summary
2.1 World Market Overview
2.1.1 Global Intravitreal Injectable Consumption 2016-2026
2.1.2 Intravitreal Injectable Consumption CAGR by Region
2.2 Intravitreal Injectable Segment by Drug
2.2.1 Anti-VEGF
2.2.2 Steroids
2.2.3 Others
2.3 Intravitreal Injectable Sales by Drug
2.3.1 Global Intravitreal Injectable Sales Market Share by Drug (2016-2021)
2.3.2 Global Intravitreal Injectable Revenue and Market Share by Drug (2016-2021)
2.3.3 Global Intravitreal Injectable Sale Price by Drug (2016-2021)
2.4 Intravitreal Injectable Segment by Disease
2.4.1 Macular Degeneration
2.4.2 Macular Edema
2.4.3 Uveitis
2.4.4 Retinal Vein Occlusion
2.4.5 Others
2.5 Intravitreal Injectable Sales by Disease
2.5.1 Global Intravitreal Injectable Sale Market Share by Disease (2016-2021)
2.5.2 Global Intravitreal Injectable Revenue and Market Share by Disease (2016-2021)
2.5.3 Global Intravitreal Injectable Sale Price by Disease (2016-2021)

3 Global Intravitreal Injectable by Company
3.1 Global Intravitreal Injectable Sales Market Share by Company
3.1.1 Global Intravitreal Injectable Sales by Company (2019-2021)
3.1.2 Global Intravitreal Injectable Sales Market Share by Company (2019-2021)
3.2 Global Intravitreal Injectable Revenue Market Share by Company
3.2.1 Global Intravitreal Injectable Revenue by Company (2019-2021)
3.2.2 Global Intravitreal Injectable Revenue Market Share by Company (2019-2021)
3.3 Global Intravitreal Injectable Sale Price by Company
3.4 Global Manufacturers Intravitreal Injectable Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Intravitreal Injectable Product Location Distribution
3.4.2 Players Intravitreal Injectable Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion

4 Intravitreal Injectable by Region
4.1 Global Intravitreal Injectable by Region
4.1.1 Global Intravitreal Injectable Sales by Region
4.1.2 Global Intravitreal Injectable Revenue by Region
4.2 Americas Intravitreal Injectable Sales Growth
4.3 APAC Intravitreal Injectable Sales Growth
4.4 Europe Intravitreal Injectable Sales Growth
4.5 Middle East & Africa Intravitreal Injectable Sales Growth

5 Americas
5.1 Americas Intravitreal Injectable Sales by Country
5.1.1 Americas Intravitreal Injectable Sales by Country (2016-2021)
5.1.2 Americas Intravitreal Injectable Revenue by Country (2016-2021)
5.2 Americas Intravitreal Injectable Sales by Drug
5.3 Americas Intravitreal Injectable Sales by Disease
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC
6.1 APAC Intravitreal Injectable Sales by Region
6.1.1 APAC Intravitreal Injectable Sales by Region (2016-2021)
6.1.2 APAC Intravitreal Injectable Revenue by Region (2016-2021)
6.2 APAC Intravitreal Injectable Sales by Drug
6.3 APAC Intravitreal Injectable Sales by Disease
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 Europe
7.1 Europe Intravitreal Injectable by Country
7.1.1 Europe Intravitreal Injectable Sales by Country (2016-2021)
7.1.2 Europe Intravitreal Injectable Revenue by Country (2016-2021)
7.2 Europe Intravitreal Injectable Sales by Drug
7.3 Europe Intravitreal Injectable Sales by Disease
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 Middle East & Africa
8.1 Middle East & Africa Intravitreal Injectable by Country
8.1.1 Middle East & Africa Intravitreal Injectable Sales by Country (2016-2021)
8.1.2 Middle East & Africa Intravitreal Injectable Revenue by Country (2016-2021)
8.2 Middle East & Africa Intravitreal Injectable Sales by Drug
8.3 Middle East & Africa Intravitreal Injectable Sales by Disease
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Country

9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Intravitreal Injectable Distributors
10.3 Intravitreal Injectable Customer

11 Global Intravitreal Injectable Market Forecast
11.1 Global Intravitreal Injectable Forecast by Region
11.1.1 Global Intravitreal Injectable Forecast by Regions (2021-2026)
11.2.2 Global Intravitreal Injectable Revenue Forecast by Regions (2021-2026)
11.2 Americas Forecast by Country
11.3 APAC Forecast by Region
11.4 Europe Forecast by Country
11.5 Middle East & Africa Forecast by Country
11.6 Global Intravitreal Injectable Forecast by Drug
11.7 Global Intravitreal Injectable Forecast by Disease

12 Key Players Analysis
12.1 Regeneron Pharmaceuticals (Eylea)
12.1.1 Regeneron Pharmaceuticals (Eylea) Company Information
12.1.2 Regeneron Pharmaceuticals (Eylea) Intravitreal Injectable Product Offered
12.1.3 Regeneron Pharmaceuticals (Eylea) Intravitreal Injectable Sales, Revenue, Price and Gross Margin (2019-2021)
12.1.4 Regeneron Pharmaceuticals (Eylea) Main Business Overview
12.1.5 Regeneron Pharmaceuticals (Eylea) Latest Developments
12.2 Allergan
12.2.1 Allergan Company Information
12.2.2 Allergan Intravitreal Injectable Product Offered
12.2.3 Allergan Intravitreal Injectable Sales, Revenue, Price and Gross Margin (2019-2021)
12.2.4 Allergan Main Business Overview
12.2.5 Allergan Latest Developments
12.3 EyePoint Pharmaceuticals
12.3.1 EyePoint Pharmaceuticals Company Information
12.3.2 EyePoint Pharmaceuticals Intravitreal Injectable Product Offered
12.3.3 EyePoint Pharmaceuticals Intravitreal Injectable Sales, Revenue, Price and Gross Margin (2019-2021)
12.3.4 EyePoint Pharmaceuticals Main Business Overview
12.3.5 EyePoint Pharmaceuticals Latest Developments
12.4 Genentech
12.4.1 Genentech Company Information
12.4.2 Genentech Intravitreal Injectable Product Offered
12.4.3 Genentech Intravitreal Injectable Sales, Revenue, Price and Gross Margin (2019-2021)
12.4.4 Genentech Main Business Overview
12.4.5 Genentech Latest Developments
12.5 Kanghong Pharmaceutical
12.5.1 Kanghong Pharmaceutical Company Information
12.5.2 Kanghong Pharmaceutical Intravitreal Injectable Product Offered
12.5.3 Kanghong Pharmaceutical Intravitreal Injectable Sales, Revenue, Price and Gross Margin (2019-2021)
12.5.4 Kanghong Pharmaceutical Main Business Overview
12.5.5 Kanghong Pharmaceutical Latest Developments
...

13 Research Findings and Conclusion

List of Tables
Table 1. Intravitreal Injectable Consumption CAGR by Region (2020-2026) & ($ Millions)
Table 2. Major Players of Anti-VEGF
Table 3. Major Players of Steroids
Table 4. Major Players of Others
Table 5. Global Intravitreal Injectable Sales by Drug (2016-2021) & (K Units)
Table 6. Global Intravitreal Injectable Sales Market Share by Drug (2016-2021)
Table 7. Global Intravitreal Injectable Revenue by Drug (2016-2021) & ($ million)
Table 8. Global Intravitreal Injectable Revenue Market Share by Drug (2016-2021)
Table 9. Global Intravitreal Injectable Sale Price by Drug (2016-2021)
Table 10. Global Intravitreal Injectable Sales by Disease (2016-2021) & (K Units)
Table 11. Global Intravitreal Injectable Sales Market Share by Disease (2016-2021)
Table 12. Global Intravitreal Injectable Value by Disease (2016-2021)
Table 13. Global Intravitreal Injectable Revenue Market Share by Disease (2016-2021)
Table 14. Global Intravitreal Injectable Sale Price by Disease (2016-2021)
Table 15. Global Intravitreal Injectable Sales by Company (2019-2021) & (K Units)
Table 16. Global Intravitreal Injectable Sales Market Share by Company (2019-2021)
Table 17. Global Intravitreal Injectable Revenue by Company (2019-2021) ($ Millions)
Table 18. Global Intravitreal Injectable Revenue Market Share by Company (2019-2021)
Table 19. Global Intravitreal Injectable Sale Price by Company (2019-2021)
Table 20. Key Manufacturers Intravitreal Injectable Producing Area Distribution and Sales Area
Table 21. Players Intravitreal Injectable Products Offered
Table 22. Intravitreal Injectable Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Intravitreal Injectable Sales by Region (2016-2021) (K Units)
Table 26. Global Intravitreal Injectable Sales Market Share by Region (2016-2021)
Table 27. Global Intravitreal Injectable Revenue by Region (2016-2021) & ($ Millions)
Table 28. Global Intravitreal Injectable Revenue Market Share by Region (2016-2021)
Table 29. Americas Intravitreal Injectable Sales by Country (2016-2021) & (K Units)
Table 30. Americas Intravitreal Injectable Sales Market Share by Country (2016-2021)
Table 31. Americas Intravitreal Injectable Revenue by Country (2016-2021) & ($ Millions)
Table 32. Americas Intravitreal Injectable Revenue Market Share by Country (2016-2021)
Table 33. Americas Intravitreal Injectable Sales by Type (2016-2021) & (K Units)
Table 34. Americas Intravitreal Injectable Sales Market Share by Drug (2016-2021)
Table 35. Americas Intravitreal Injectable Sales by Disease (2016-2021) & (K Units)
Table 36. Americas Intravitreal Injectable Sales Market Share by Disease (2016-2021)
Table 37. APAC Intravitreal Injectable Sales by Region (2016-2021) & (K Units)
Table 38. APAC Intravitreal Injectable Sales Market Share by Region (2016-2021)
Table 39. APAC Intravitreal Injectable Revenue by Region (2016-2021) & ($ Millions)
Table 40. APAC Intravitreal Injectable Revenue Market Share by Region (2016-2021)
Table 41. APAC Intravitreal Injectable Sales by Drug (2016-2021) & (K Units)
Table 42. APAC Intravitreal Injectable Sales Market Share by Drug (2016-2021)
Table 43. APAC Intravitreal Injectable Sales by Disease (2016-2021) & (K Units)
Table 44. APAC Intravitreal Injectable Sales Market Share by Disease (2016-2021)
Table 45. Europe Intravitreal Injectable Sales by Country (2016-2021) & (K Units)
Table 46. Europe Intravitreal Injectable Sales Market Share by Country (2016-2021)
Table 47. Europe Intravitreal Injectable Revenue by Country (2016-2021) & ($ Millions)
Table 48. Europe Intravitreal Injectable Revenue Market Share by Country (2016-2021)
Table 49. Europe Intravitreal Injectable Sales by Type (2016-2021) & (K Units)
Table 50. Europe Intravitreal Injectable Sales Market Share by Drug (2016-2021)
Table 51. Europe Intravitreal Injectable Sales by Disease (2016-2021) & (K Units)
Table 52. Europe Intravitreal Injectable Sales Market Share by Disease (2016-2021)
Table 53. Middle East & Africa Intravitreal Injectable Sales by Country (2016-2021) & (K Units)
Table 54. Middle East & Africa Intravitreal Injectable Sales Market Share by Country (2016-2021)
Table 55. Middle East & Africa Intravitreal Injectable Revenue by Country (2016-2021) & ($ Millions)
Table 56. Middle East & Africa Intravitreal Injectable Revenue Market Share by Country (2016-2021)
Table 57. Middle East & Africa Intravitreal Injectable Sales by Drug (2016-2021) & (K Units)
Table 58. Middle East & Africa Intravitreal Injectable Sales Market Share by Drug (2016-2021)
Table 59. Middle East & Africa Intravitreal Injectable Sales by Disease (2016-2021) & (K Units)
Table 60. Middle East & Africa Intravitreal Injectable Sales Market Share by Disease (2016-2021)
Table 61. Key and Potential Regions of Intravitreal Injectable
Table 62. Key Application and Potential Industries of Intravitreal Injectable
Table 63. Key Challenges of Intravitreal Injectable
Table 64. Key Trends of Intravitreal Injectable
Table 65. Intravitreal Injectable Distributors List
Table 66. Intravitreal Injectable Customer List
Table 67. Global Intravitreal Injectable Sales Forecast by Region (2021-2026) & (K Units)
Table 68. Global Intravitreal Injectable Consumption Market Forecast by Region
Table 69. Global Intravitreal Injectable Revenue Forecast by Region (2021-2026) & ($ millions)
Table 70. Global Intravitreal Injectable Revenue Market Share Forecast by Region (2021-2026)
Table 71. Americas Intravitreal Injectable Sales Forecast by Country (2021-2026) & (K Units)
Table 72. Americas Intravitreal Injectable Revenue Forecast by Country (2021-2026) & ($ millions)
Table 73. APAC Intravitreal Injectable Sales Forecast by Region (2021-2026) & (K Units)
Table 74. APAC Intravitreal Injectable Revenue Forecast by Region (2021-2026) & ($ millions)
Table 75. Europe Intravitreal Injectable Sales Forecast by Country (2021-2026) & (K Units)
Table 76. Europe Intravitreal Injectable Revenue Forecast by Country (2021-2026) & ($ millions)
Table 77. Middle East & Africa Intravitreal Injectable Sales Forecast by Country (2021-2026) & (K Units)
Table 78. Middle East & Africa Intravitreal Injectable Revenue Forecast by Country (2021-2026) & ($ millions)
Table 79. Global Intravitreal Injectable Sales Forecast by Drug (2021-2026) & (K Units)
Table 80. Global Intravitreal Injectable Sales Market Share Forecast by Drug (2021-2026)
Table 81. Global Intravitreal Injectable Revenue Forecast by Drug (2021-2026) & ($ Millions)
Table 82. Global Intravitreal Injectable Revenue Market Share Forecast by Drug (2021-2026)
Table 83. Global Intravitreal Injectable Sales Forecast by Disease (2021-2026) & (K Units)
Table 84. Global Intravitreal Injectable Sales Market Share Forecast by Disease (2021-2026)
Table 85. Global Intravitreal Injectable Revenue Forecast by Disease (2021-2026) & ($ Millions)
Table 86. Global Intravitreal Injectable Revenue Market Share Forecast by Disease (2021-2026)
Table 87. Regeneron Pharmaceuticals (Eylea) Basic Information, Intravitreal Injectable Manufacturing Base, Sales Area and Its Competitors
Table 88. Regeneron Pharmaceuticals (Eylea) Intravitreal Injectable Product Offered
Table 89. Regeneron Pharmaceuticals (Eylea) Intravitreal Injectable Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 90. Regeneron Pharmaceuticals (Eylea) Main Business
Table 91. Regeneron Pharmaceuticals (Eylea) Latest Developments
Table 92. Allergan Basic Information, Intravitreal Injectable Manufacturing Base, Sales Area and Its Competitors
Table 93. Allergan Intravitreal Injectable Product Offered
Table 94. Allergan Intravitreal Injectable Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 95. Allergan Main Business
Table 96. Allergan Latest Developments
Table 97. EyePoint Pharmaceuticals Basic Information, Intravitreal Injectable Manufacturing Base, Sales Area and Its Competitors
Table 98. EyePoint Pharmaceuticals Intravitreal Injectable Product Offered
Table 99. EyePoint Pharmaceuticals Intravitreal Injectable Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 100. EyePoint Pharmaceuticals Main Business
Table 101. EyePoint Pharmaceuticals Latest Developments
Table 102. Genentech Basic Information, Intravitreal Injectable Manufacturing Base, Sales Area and Its Competitors
Table 103. Genentech Intravitreal Injectable Product Offered
Table 104. Genentech Intravitreal Injectable Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 105. Genentech Main Business
Table 106. Genentech Latest Developments
Table 107. Kanghong Pharmaceutical Basic Information, Intravitreal Injectable Manufacturing Base, Sales Area and Its Competitors
Table 108. Kanghong Pharmaceutical Intravitreal Injectable Product Offered
Table 109. Kanghong Pharmaceutical Intravitreal Injectable Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 110. Kanghong Pharmaceutical Main Business
Table 111. Kanghong Pharmaceutical Latest Developments

List of Figures
Figure 1. Picture of Intravitreal Injectable
Figure 2. Intravitreal Injectable Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Intravitreal Injectable Sales Growth Rate 2016-2026 (K Units)
Figure 7. Global Intravitreal Injectable Revenue Growth Rate 2016-2026 ($ Millions)
Figure 8. Intravitreal Injectable Sales by Region (2021 & 2026) & ($ millions)
Figure 9. Product Picture of Anti-VEGF
Figure 10. Product Picture of Steroids
Figure 11. Product Picture of Others
Figure 12. Global Intravitreal Injectable Sales Market Share by Drug in 2020
Figure 13. Global Intravitreal Injectable Revenue Market Share by Drug (2016-2021)
Figure 14. Intravitreal Injectable Consumed in Macular Degeneration
Figure 15. Global Intravitreal Injectable Market: Macular Degeneration (2016-2021) & (K Units)
Figure 16. Intravitreal Injectable Consumed in Macular Edema
Figure 17. Global Intravitreal Injectable Market: Macular Edema (2016-2021) & (K Units)
Figure 18. Intravitreal Injectable Consumed in Uveitis
Figure 19. Global Intravitreal Injectable Market: Uveitis (2016-2021) & (K Units)
Figure 20. Intravitreal Injectable Consumed in Retinal Vein Occlusion
Figure 21. Global Intravitreal Injectable Market: Retinal Vein Occlusion (2016-2021) & (K Units)
Figure 22. Intravitreal Injectable Consumed in Others
Figure 23. Global Intravitreal Injectable Market: Others (2016-2021) & (K Units)
Figure 24. Global Intravitreal Injectable Sales Market Share by Disease (2016-2021)
Figure 25. Global Intravitreal Injectable Revenue Market Share by Disease in 2020
Figure 26. Intravitreal Injectable Revenue Market by Company in 2020 ($ Million)
Figure 27. Global Intravitreal Injectable Revenue Market Share by Company in 2020
Figure 28. Global Intravitreal Injectable Sales Market Share by Regions (2016-2021)
Figure 29. Global Intravitreal Injectable Revenue Market Share by Region in 2020
Figure 30. Americas Intravitreal Injectable Sales 2016-2021 (K Units)
Figure 31. Americas Intravitreal Injectable Revenue 2016-2021 ($ Millions)
Figure 32. APAC Intravitreal Injectable Sales 2016-2021 (K Units)
Figure 33. APAC Intravitreal Injectable Revenue 2016-2021 ($ Millions)
Figure 34. Europe Intravitreal Injectable Sales 2016-2021 (K Units)
Figure 35. Europe Intravitreal Injectable Revenue 2016-2021 ($ Millions)
Figure 36. Middle East & Africa Intravitreal Injectable Sales 2016-2021 (K Units)
Figure 37. Middle East & Africa Intravitreal Injectable Revenue 2016-2021 ($ Millions)
Figure 38. Americas Intravitreal Injectable Sales Market Share by Country in 2020
Figure 39. Americas Intravitreal Injectable Revenue Market Share by Country in 2020
Figure 40. Americas Intravitreal Injectable Sales Market Share by Drug in 2020
Figure 41. Americas Intravitreal Injectable Sales Market Share by Disease in 2020
Figure 42. United States Intravitreal Injectable Revenue Growth 2016-2021 ($ Millions)
Figure 43. Canada Intravitreal Injectable Revenue Growth 2016-2021 ($ Millions)
Figure 44. Mexico Intravitreal Injectable Revenue Growth 2016-2021 ($ Millions)
Figure 45. Brazil Intravitreal Injectable Revenue Growth 2016-2021 ($ Millions)
Figure 46. APAC Intravitreal Injectable Sales Market Share by Region in 2020
Figure 47. APAC Intravitreal Injectable Revenue Market Share by Regions in 2020
Figure 48. APAC Intravitreal Injectable Sales Market Share by Drug in 2020
Figure 49. APAC Intravitreal Injectable Sales Market Share by Disease in 2020
Figure 50. China Intravitreal Injectable Revenue Growth 2016-2021 ($ Millions)
Figure 51. Japan Intravitreal Injectable Revenue Growth 2016-2021 ($ Millions)
Figure 52. Korea Intravitreal Injectable Revenue Growth 2016-2021 ($ Millions)
Figure 53. Southeast Asia Intravitreal Injectable Revenue Growth 2016-2021 ($ Millions)
Figure 54. India Intravitreal Injectable Revenue Growth 2016-2021 ($ Millions)
Figure 55. Australia Intravitreal Injectable Revenue Growth 2016-2021 ($ Millions)
Figure 56. Europe Intravitreal Injectable Sales Market Share by Country in 2020
Figure 57. Europe Intravitreal Injectable Revenue Market Share by Country in 2020
Figure 58. Europe Intravitreal Injectable Sales Market Share by Drug in 2020
Figure 59. Europe Intravitreal Injectable Sales Market Share by Disease in 2020
Figure 60. Germany Intravitreal Injectable Revenue Growth 2016-2021 ($ Millions)
Figure 61. France Intravitreal Injectable Revenue Growth 2016-2021 ($ Millions)
Figure 62. UK Intravitreal Injectable Revenue Growth 2016-2021 ($ Millions)
Figure 63. Italy Intravitreal Injectable Revenue Growth 2016-2021 ($ Millions)
Figure 64. Russia Intravitreal Injectable Revenue Growth 2016-2021 ($ Millions)
Figure 65. Middle East & Africa Intravitreal Injectable Sales Market Share by Country in 2020
Figure 66. Middle East & Africa Intravitreal Injectable Revenue Market Share by Country in 2020
Figure 67. Middle East & Africa Intravitreal Injectable Sales Market Share by Drug in 2020
Figure 68. Middle East & Africa Intravitreal Injectable Sales Market Share by Disease in 2020
Figure 69. Egypt Intravitreal Injectable Revenue Growth 2016-2021 ($ Millions)
Figure 70. South Africa Intravitreal Injectable Revenue Growth 2016-2021 ($ Millions)
Figure 71. Israel Intravitreal Injectable Revenue Growth 2016-2021 ($ Millions)
Figure 72. Turkey Intravitreal Injectable Revenue Growth 2016-2021 ($ Millions)
Figure 73. GCC Country Intravitreal Injectable Revenue Growth 2016-2021 ($ Millions)
Figure 74. Channels of Distribution
Figure 75. Distributors Profiles

Report Title: Global Intravitreal Injectable Market Growth 2021-2026


Your Details
Valid Invalid number

SELECT A FORMAT

ADD TO CART BUY NOW